Related Experiment Video
Updated: Mar 28, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
The Cardiac Complications of Methamphetamines
Elizabeth D Paratz1, Neil J Cunningham2, Andrew I MacIsaac1
1Cardiology Department, St Vincent's Hospital Melbourne, Vic, Australia.
Rising methamphetamine use and purity increase cardiac risks in Australia. Abstinence and treatment can reverse methamphetamine-induced cardiac pathology, improving patient outcomes.
Area of Science:
- Cardiology
- Toxicology
- Public Health
Background:
- Methamphetamine (ice) abuse is increasing in Australia, with rising drug purity.
- This trend escalates demands on medical services and public health resources.
- Cardiovascular complications are a significant cause of mortality in methamphetamine users.
Purpose of the Study:
- To review the cardiovascular pathology associated with methamphetamine abuse.
- To discuss the management of methamphetamine-induced cardiac complications.
- To highlight the impact of rising methamphetamine use on Australian healthcare.
Main Methods:
- Literature review of cardiovascular complications linked to methamphetamine.
- Analysis of current trends in methamphetamine abuse and purity.
- Discussion of clinical management strategies for affected patients.
Main Results:
- Hypertension, aortic dissection, acute coronary syndromes, pulmonary arterial hypertension, and cardiomyopathy are common.
- Methamphetamine-associated cardiomyopathy is a key concern.
- Cardiovascular pathology is directly linked to the toxic effects of methamphetamine.
Conclusions:
- Methamphetamine abuse poses a substantial threat to cardiovascular health in Australia.
- Early diagnosis and intervention, including abstinence, are crucial for managing cardiac pathology.
- Individualized treatment approaches are essential for addressing methamphetamine-induced cardiac complications.
More Related Videos
12:31A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain
Published on: November 14, 2012
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Heart Failure Drugs: Inotropic Agents
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Coronary Artery Disease III: Clinical Manifestations